Clinical trial
Glycosaminoglycan Scores as Early Detection Biomarkers in Bladder Urothelial Carcinoma
NCT05799456 is registered in ClinicalTrials.gov with Jens Nielsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glycosaminoglycan Scores as Early Detection Biomarkers in Bladder Urothelial Carcinoma
- Lead sponsor
- Jens Nielsen
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2018
- Completion date
- February 28, 2023
- Enrollment
- 106 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer